MariMed Posts Record Q1 2021 Results, Revenue Spikes 230%, EBITDA Up By 764% YoY
MariMed, Inc. (OTCQX: MRMD) disclosed Monday its core revenue spiked 230% year-over-year, reaching $24.6 million in the first quarter of 2021, marking it the company's highest-ever quarter of core cannabis revenue and profitability.
